```html

Yeast‑Induced Esophagitis

Overview

Yeast‑induced esophagitis, also called Candida esophagitis, is an inflammation of the lining of the esophagus caused by an overgrowth of the fungus Candida (most often Candida albicans). The fungus normally lives in the mouth, throat, and gastrointestinal tract in small numbers without causing problems. When the immune system is weakened or the normal balance of microorganisms is disrupted, Candida can proliferate and invade the esophageal mucosa, producing painful symptoms.

Who it affects

• Adults with compromised immunity: HIV/AIDS, organ‑transplant recipients, patients on chemotherapy, or those taking high‑dose corticosteroids.
• People with chronic diseases that impair swallowing or esophageal motility (e.g., achalasia, esophageal strictures).
• Individuals on long‑term broad‑spectrum antibiotics or proton‑pump inhibitors (PPIs) that alter normal flora.
• Infants and young children, particularly those born prematurely or receiving antibiotics.

Prevalence

• Among patients with HIV/AIDS, Candida esophagitis occurs in 15‑40% of those with CD4 counts < 200 cells/µL (CDC, 2023).
• In immunocompetent adults, the condition is rare, accounting for less than 5% of all cases of esophagitis seen in endoscopy suites.<sup>1</sup>
• In hospitalized patients on broad‑spectrum antibiotics, incidence ranges from 2–6% per year.<sup>2</sup>

Symptoms

Symptoms can vary from mild to severe and may develop gradually over several days.

• Odynophagia – painful swallowing; often described as a burning or stabbing sensation.
• Dysphagia – difficulty swallowing, especially liquids; can progress to solids if inflammation worsens.
• Retrosternal pain – a persistent ache behind the breastbone that may worsen after meals.
• Chest discomfort – can mimic heartburn or angina; patients sometimes report a “pressure” sensation.
• Upper‑mid abdominal pain – less common, may be due to reflux irritation.
• Hoarseness or chronic cough – from micro‑aspiration of fungal material.
• Weight loss – secondary to reduced oral intake because of pain.
• Fever – may appear in immunocompromised patients with systemic candidiasis.
• Oral thrush – white patches on the tongue or palate that can be a clue to an esophageal Candida infection.
• Unexplained nausea or vomiting – especially if the esophagus is severely inflamed.

Causes and Risk Factors

Primary cause

The disease results from uncontrolled growth of Candida species, which penetrate the squamous epithelium of the esophagus. The fungus produces enzymes (e.g., proteases, phospholipases) that break down tissue, leading to ulceration and inflammation.

Key risk factors

• Immunosuppression – HIV infection with CD4 < 200, chemotherapy, bone‑marrow or solid‑organ transplantation, biologic agents (e.g., TNF‑α inhibitors).
• Chronic acid suppression – long‑term use of PPIs or H2‑blockers reduces gastric acidity, which normally limits fungal overgrowth.
• Broad‑spectrum antibiotics – eliminate bacterial competitors, encouraging Candida proliferation.
• Diabetes mellitus – high glucose levels in tissues favor fungal growth; diabetic patients have a 1.5‑fold increased risk.<sup>3</sup>
• Malnutrition or severe weight loss – impairs mucosal immunity.
• Smoking and alcohol abuse – disrupt mucosal barriers.
• Neurologic disorders – stroke, Parkinson’s disease, or dementia can cause dysphagia and aspiration, increasing fungal exposure.
• Infancy – premature infants receiving antibiotics and parenteral nutrition are particularly vulnerable.

Diagnosis

Accurate diagnosis requires a combination of clinical suspicion, endoscopic evaluation, and laboratory testing.

1. Clinical assessment

• Detailed history focusing on immune status, medication use, and symptom chronology.
• Physical exam for oral thrush, weight loss, or signs of systemic infection.

2. Upper endoscopy (esophagogastroduodenoscopy, EGD)

Considered the gold standard. Typical findings include:

• White, raised plaques adherent to the mucosa that can be scraped off, often revealing a reddened, inflamed base.
• Focal ulcerations or erosions.
• Occasional “pseudomembranes.”

During the procedure, biopsies are taken for histology and culture.

3. Histopathology

H&E or special stains (periodic acid‑Schiff, Gomori methenamine silver) reveal yeast‑forms and pseudohyphae invading the epithelium.

4. Microbiologic culture

Specimens from biopsy or brushings are cultured on Sabouraud agar to identify Candida species and assess antifungal susceptibility.

5. Non‑invasive tests (limited utility)

• Empiric trial of fluconazole: If symptoms improve within 3–5 days, the diagnosis is often presumed.
• Serum β‑D‑glucan: May be elevated in disseminated candidiasis but not specific for esophageal disease.

Treatment Options

Therapy aims to eradicate the fungus, relieve symptoms, and address underlying risk factors.

Antifungal Medications

Drug	Typical Adult Dose	Duration	Comments
Fluconazole	200–400 mg PO daily	14–21 days	First‑line; good oral bioavailability; adjust for renal impairment.
Itraconazole	200 mg PO BID	14–21 days	Useful for fluconazole‑resistant strains; requires acidic gastric environment.
Voriconazole	200 mg PO BID	14–21 days	Broad‑spectrum; reserved for azole‑resistant Candida.
Echinocandins (caspofungin, micafungin)	IV 50 mg daily (caspofungin)	7–14 days	Preferred for severely ill or azole‑resistant cases; IV only.

Patients who are unable to take oral medication (e.g., severe dysphagia) may start with IV echinocandin therapy and switch to oral azoles once tolerating intake.

Adjunctive Measures

• Proton‑pump inhibitor cessation – if clinically feasible, reduce acid suppression to restore normal flora.
• Optimize glycemic control in diabetic patients.
• Review antibiotics – discontinue or de‑escalate broad‑spectrum agents when possible.
• Treat oral thrush simultaneously with topical nystatin or clotrimazole lozenges.

Procedural Interventions

Rarely required, but in refractory cases endoscopic dilation may be needed if strictures develop. Surgical esophagectomy is a last resort for life‑threatening complications such as perforation.

Living with Yeast‑Induced Esophagitis

Daily Management Tips

• Medication adherence – finish the entire prescribed course even if symptoms improve.
• Soft, non‑irritating diet – warm soups, oatmeal, mashed potatoes, smoothies; avoid spicy, acidic, or very hot foods that aggravate pain.
• Stay hydrated – sip water or non‑caffeinated fluids throughout the day to keep the throat moist.
• Oral hygiene – brush twice daily, use an alcohol‑free mouthwash, and consider probiotic lozenges to restore normal flora.
• Monitor blood glucose (if diabetic) – target HbA1c < 7% as recommended by ADA.
• Follow‑up endoscopy – usually at 4–6 weeks if symptoms persist, to ensure healing.
• Stress management – chronic illness can increase cortisol, which may further weaken immunity; practice relaxation techniques.

When to Contact Your Provider

• Symptoms persist beyond 2 weeks of therapy.
• New fever, chills, or worsening chest pain.
• Difficulty swallowing liquids (risk of dehydration).
• Side effects from antifungal medication (e.g., severe rash, liver enzyme elevation).

Prevention

• Limit unnecessary antibiotic use – ask your clinician about the shortest effective course.
• Use the lowest effective dose of PPIs and consider step‑down therapy when acid suppression is no longer needed.
• Maintain good oral health – regular dental check‑ups and daily brushing.
• Control chronic diseases – keep HIV viral load suppressed, maintain target CD4 counts, manage diabetes, and avoid tobacco.
• Probiotic supplementation – strains such as Lactobacillus rhamnosus GG may help preserve bacterial balance, though evidence is moderate (Mayo Clinic Proceedings, 2020).
• Nutrition – a diet rich in fiber, vitamins A and C, and zinc supports mucosal immunity.

Complications

If left untreated or inadequately managed, Candida esophagitis can lead to serious outcomes:

• Esophageal ulceration and bleeding – may present as hematemesis or melena.
• Stricture formation – fibrotic narrowing requiring dilation.
• Perforation – rare but life‑threatening; can cause mediastinitis.
• Aspiration pneumonia – especially in patients with dysphagia.
• Disseminated candidiasis – bloodstream infection in severely immunocompromised hosts, with mortality >40% without prompt therapy.<sup>4</sup>

When to Seek Emergency Care

References

```